Valuation: Yuhan Corporation

Market Cap 5,603B 3.94B 3.41B 3.18B 2.92B 5.52B 374B 5.58B 37.36B 14.66B 187B 14.79B 14.46B 620B P/E 2026 *
36.9x
P/E 2027 * 26.9x
Enterprise Value 5.52B 3.88M 3.36M 3.13M 2.88M 5.44M 369M 5.5M 36.82M 14.45M 185M 14.58M 14.26M 612M EV / Sales 2026 *
2.35x
EV / Sales 2027 * 2.12x
Free-Float
64.28%
Yield 2026 *
0.75%
Yield 2027 * 0.76%
1 day+0.40%
1 week+6.83%
Current month+2.18%
1 month+6.68%
3 months-17.02%
6 months-30.07%
Current year-33.19%
1 week 71,300
Extreme 71300
76,800
1 month 66,200
Extreme 66200
77,100
Current year 65,000
Extreme 65000
115,900
1 year 65,000
Extreme 65000
129,200
3 years 52,285.71
Extreme 52285.714285
166,900
5 years 47,571.43
Extreme 47571.428571
166,900
10 years 24,550.49
Extreme 24550.486545
166,900
Manager TitleAgeSince
Chief Executive Officer 71 2021-03-18
Director of Finance/CFO 58 -
President 67 2024-03-14
Director TitleAgeSince
Chairman 74 2021-03-18
Director/Board Member 71 2015-03-19
Director/Board Member 62 2020-02-29
Date Insider Type Main position Quantity % Market Cap.
6/30/25 Buy

Chairperson

200 0.0002%
6/25/25 Buy

Chief Executive Officer

720 0.0009%
6/24/25 Buy 231 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
+0.40%+6.83%-34.64%+7.29% 3.94B
+0.26%-1.56%+58.84%+22.22% 317B
+1.16%+2.42%+38.61%-8.59% 72.79B
+0.43%+0.37%+37.46%+97.10% 9.91B
+2.42%-5.13%-3.90%-5.54% 8.16B
+2.76%+8.47%-26.39%-14.85% 4.51B
+2.46%+2.71%-17.02%+21.19% 3.71B
+8.46%+0.73%+24.99%+45.77% 2.73B
-0.19%-0.38%-2.51%-3.33% 2.24B
+1.75%-0.22%-25.96%+29.50% 1.79B
Average +1.99%+1.00%+4.95%+19.08% 42.67B
Weighted average by Cap. +0.56%-1.18%+50.38%+17.68%

Financials

2026 *2027 *
Net sales 2,354B 1.65B 1.43B 1.34B 1.23B 2.32B 157B 2.34B 15.69B 6.16B 78.69B 6.21B 6.08B 261B 2,572B 1.81B 1.57B 1.46B 1.34B 2.53B 172B 2.56B 17.15B 6.73B 85.98B 6.79B 6.64B 285B
Net income 157B 110M 95.59M 89.11M 81.96M 155M 10.49B 156M 1.05B 411M 5.25B 415M 405M 17.39B 209B 147M 127M 119M 109M 206M 13.99B 209M 1.4B 548M 7B 553M 541M 23.19B
Net Debt -80.13B -56.31M -48.77M -45.46M -41.81M -78.94M -5.35B -79.82M -534M -210M -2.68B -211M -207M -8.87B -162B -114M -98.49M -91.81M -84.44M -159M -10.81B -161M -1.08B -423M -5.41B -427M -418M -17.92B
Logo Yuhan Corporation
Yuhan Corp is a Korea-based company primarily engaged in the manufacture and sale of pharmaceuticals. The Company operates its business through three segments. The Pharmaceutical Business segment manufactures and sells non-prescription drugs, such as analgesics, anti-inflammatory drugs, probiotics, nutritional supplements, and wound-healing agents, as well as prescription drugs, including treatments for diabetes, hyperlipidemia, hypertension, hepatitis, acquired immunodeficiency syndrome (AIDS), bone marrow cancer, cough suppressants, and breast cancer. The Overseas Business segment engages in the export of AIDS treatment intermediates. The Healthcare Business segment provides household goods, such as bleach. Additionally, the Company sells licenses. The Company sells its products in both domestic and overseas markets.
Employees
2,087
Date Price Change Volume
26-08-05 ₩75,100.00 +0.40% 238,250
26-08-04 ₩74,800.00 +1.63% 216,144
26-08-03 ₩73,600.00 +0.14% 225,373
26-07-31 ₩73,500.00 -0.68% 321,744
26-07-30 ₩74,000.00 +5.26% 404,762
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
75,100.00KRW
Average target price
124,000.00KRW
Spread / Average Target
+65.11%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A000100 Stock